Please login to read the full text of the article.
If you have no account yet, please register now.
Posted on
Previous Article
« Higher risk of severe cardiovascular events seen in months after starting ustekinumab therapy Next Article
Timing of radiation plus immunotherapy could be key to antitumor response in kidney cancer »
« Higher risk of severe cardiovascular events seen in months after starting ustekinumab therapy Next Article
Timing of radiation plus immunotherapy could be key to antitumor response in kidney cancer »
Related Articles
October 29, 2021
Cabozantinib an option for kidney cancer with brain metastases
© 2021 Medicom Medical Publishers. All rights reserved. Terms and Conditions | Privacy Policy